Dr. Steve Pakola’s Perspective on the Transformative Power of Advanced Therapeutics


Click here to watch the video version of this podcast.

Steve Pakola, MD, has held several high-profile leadership positions over his many decades in eye care. As the lead inventor and program lead for Jetrea (ocriplasmin), he’s long believed in the transformative power of advanced therapeutics. Today, he serves as chief medical officer at REGENXBIO, where he helps advance the company’s mission of improving lives through the curative potential of gene therapy.

Steve Pakola, MD, Chief Medical Officer – REGENXBIO